Abstract Body

Emerging evidence suggests that the HIV-1 integrase (IN) enzyme plays a critical noncatalytic role in virion maturation, which involves its binding to the viral RNA genome (gRNA) (Kessl et al., Cell 2016). We demonstrated that inhibition of IN-gRNA interactions underlies the pleiotropic effects of numerous class II IN mutations in virus replication (Elliott et al., eLife 2020). In the same study, we showed that IN tetramerization is required for RNA binding and that class II mutations inhibit IN binding to the vRNA through three distinct mechanisms; (i) by decreasing the levels of IN in virions and precluding IN-vRNA interactions, (ii) by impairing IN tetramerization, and (iii) by directly inhibiting IN-vRNA interactions. In addition, we have shown that inhibition of IN-gRNA interactions leads to mislocalization of the gRNA and possibly IN in virions, and their subsequent degradation in target cells (Madison et al., J. Vir. 2017, Elliott et al., eLife 2020), primarily due to lack of protection by the capsid lattice (Eschbach et al., J. Vir. 2020). Building on these key discoveries we continue to decipher the rules of HIV-1 IN-gRNA interactions, how IN-gRNA interactions mediate proper virion maturation and how infected cells sense aberrant particles generated upon inhibition of IN-RNA interactions and capsid destabilization. For example, we have isolated compensatory substitutions in the background of a class II IN (R269A/K273A) variant that directly inhibits IN binding to the gRNA. We found that additional D256N and D270N substitutions in the C-terminal domain (CTD) of IN restored its ability to bind gRNA and led to the formation of infectious particles with correctly matured morphology. Furthermore, reinstating the overall positive electrostatic potential of the CTD through individual D256R or D256K substitutions was sufficient to restore IN-RNA binding and infectivity for the R269A/K273A as well as the R262A/R263A class II IN mutants. As part of the CROI symposium, we will overview these key discoveries and highlight unpublished data demonstrating that electrostatic interactions play a key role in mediating IN binding to the gRNA. Understanding the molecular basis of the second non-catalytic function of IN will not only provide fundamental insight to HIV-1 replication but also help in the development of novel therapies that can complement INSTIs.